New insights into the function of Atg9  by Webber, Jemma L. & Tooze, Sharon A.
FEBS Letters 584 (2010) 1319–1326journal homepage: www.FEBSLetters .orgReview
New insights into the function of Atg9
Jemma L. Webber, Sharon A. Tooze *
London Research Institute, Cancer Research UK, 44 Lincoln’s Inn Fields, London WC2A 3PX, United Kingdom
a r t i c l e i n f o a b s t r a c tArticle history:
Received 7 December 2009
Revised 8 January 2010
Accepted 12 January 2010
Available online 17 January 2010
Edited by Noboru Mizushima
Keywords:
p38 MAPK interacting protein
p38 mitogen activated protein kinase
Autophagosome0014-5793/$36.00  2010 Federation of European Bio
doi:10.1016/j.febslet.2010.01.020
Abbreviations: Atg, autophagy related; Cvt, cyto
MAPK, mitogen activated protein kinase; p38IP, p3
MEF, mouse embryonic ﬁbroblast; PI3K, phospha
phosphatidylinositol-3-phosphate; S6K, S6 kinase; ST
TBK-1, TANK-binding kinase 1; TOR, target of rapamy
* Corresponding author. Fax: +44 207 269 3417.
E-mail address: sharon.tooze@cancer.org.uk (S.A. TAutophagy is a lysosomal degradation pathway that is essential for cellular homeostasis. Identiﬁca-
tion of more than 30 autophagy related proteins including a multi-spanning membrane protein,
Atg9, has increased our understanding of the molecular mechanisms involved in autophagy. Atg9
is required for autophagy in several eukaryotic organisms although its function is unknown.
Recently, we identiﬁed a novel interacting partner of mAtg9, p38 MAPK interacting protein,
p38IP. We summarise recent data on the role of Atg9 trafﬁcking in yeast and mammalian autophagy
and discuss the role of p38IP and p38 MAPK in regulation of mAtg9 trafﬁcking and autophagy.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Normal cell growth and development requires a balance be-
tween protein synthesis and protein degradation. Eukaryotic cells
have two mechanisms for degrading proteins, namely, the ubiqui-
tin-proteasome system that is responsible for degradation of short-
lived proteins, and autophagy that acts to degrade long-lived pro-
teins and organelles [1]. Autophagy occurs in basal conditions to
perform homeostatic functions and is upregulated upon nutrient
deprivation or cellular stress to provide amino acids and maintain
energy levels. Autophagy is therefore essential for the survival of
yeast during starvation and in higher eukaryotes it is required
shortly after birth when the trans-placental food supply is lost (re-
viewed by Ref. [2]). In addition, autophagy is found to be involved
in lifespan extension, cellular development, and has been impli-
cated in cancer and neurodegenerative diseases such as Hunting-
ton’s, Alzheimer’s and Parkinson’s diseases [2].
Autophagy begins by the elongation of a membrane cisternae to
enclose cytoplasmic material into a double-membrane vesicle
called the autophagosome (Fig. 1). The autophagosome fuses with
the vacuole in yeast and plants or the lysosome in mammalian cells
to enable degradation of the sequestered contents by vacuolar/
lysosomal hydrolases. Yeast genetic screens have identiﬁed morechemical Societies. Published by E
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ooze).than 30 autophagy related (Atg) proteins that are required for
autophagy [3]. Many of these Atg proteins are found to transiently
localise to a distinct site that is juxta-posed to the vacuolar mem-
brane termed the pre-autophagosomal structure or phagophore
assembly site (PAS). Correct recruitment of Atg proteins to this site
is required for normal autophagy and thus it is a potential site for
organisation of the forming autophagosome [4,5]. Orthologues of
many of the Atg proteins have been identiﬁed in higher eukaryotes
including Caenorhabditis elegans, Drosophila, mice and humans (for
review see [6]).
The Atg proteins can be categorised into several distinct com-
plexes that collectively make up the core machinery required for
autophagy. This core machinery comprises a protein kinase com-
plex and a phosphatidylinositol 3-kinase (PI3K) complex, two
ubiquitin-like conjugation systems, as well as the multi-spanning
membrane protein Atg9.
The protein kinase complex includes the serine/threonine pro-
tein kinase Atg1 that forms a complex with a number of Atg pro-
teins including Atg13 and Atg17. In yeast the formation of a
functional complex of Atg1, Atg13, Atg17, Atg29 and Atg31 is re-
quired for autophagy and is negatively regulated by the protein ki-
nase target of rapamycin (TOR). Atg1 orthologues in Drosophila and
mammals are also found to regulate autophagy downstream of
TOR signaling (reviewed by Ref. [7]).
The PI3K complex consists of the PI3K, Vps34, its regulatory
subunit, Vps15, and Vps30/Atg6 and Atg14 [8]. This complex ap-
pears to play an essential role in the induction of autophagy. It is
one of the ﬁrst components recruited to the forming autophago-
some and is required for localisation of autophagy proteins to the
PAS. In mammalian cells, hVps34, the Vps15 homologue, p150,lsevier B.V. All rights reserved.
Fig. 1. Schematic representation of autophagy. During autophagy cytoplasmic components are sequestered into a double-membrane vesicle termed the autophagosome.
Sequestration begins by the expansion of a membrane structure of unknown origin that is called the pre-autophagosomal structure or phagophore assembly site (PAS) in
yeast. The PAS then expands into the phagophore or isolation membrane. Sequestration can be either non-speciﬁc resulting in the sequestration of bulk cytoplasm, or speciﬁc
involving the engulfment of speciﬁc cargoes such as protein aggregates and bacteria. Following fusion of the autophagosome with the vacuole or endosomal and lysosomal
membranes in mammals, the inner autophagic vesicle and its contents are degraded by vacuolar or lysosomal hydrolases.
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essential for autophagy (reviewed by Ref. [9]). The function of
phosphatidylinositol-3-phosphate (PI3P) in the early stage of
autophagy is not clear, although it has been suggested to be re-
quired for increasing the size of the sequestering membrane as
well as recruiting PI3P-binding proteins [10].
Two ubiquitin-like conjugation pathways are required for vesi-
cle expansion, namely the Atg12–Atg5 and the Atg8–PE conjuga-
tion systems. Although these proteins have no clear sequence
homology to ubiquitin, crystallisation studies revealed a conserved
ubiquitin fold in both Atg8 and Atg12. In the ﬁrst pathway, the
ubiquitin-like protein Atg12 is conjugated to Atg5 by the action
of E1- and E2-like enzymes, Atg7 and Atg10, respectively (re-
viewed by Ref. [11]). The Atg12–Atg5 conjugate can then associate
with Atg16 and the complex is then recruited to the elongating
membrane. The Atg12–Atg5–Atg16 complex is responsible for
recruiting a second ubiquitin-like protein Atg8, to the membrane
[12]. Atg8 is conjugated not to another protein, but to an abundant
membrane lipid phosphatidylethanolamine (PE). This conjugation
is catalysed by the E1-like enzyme Atg7 and E2-like enzyme
Atg3. Furthermore, the Atg12–Atg5-conjugate is found to act as
an E3-like enzyme in vitro facilitating the conjugation of Atg8 to
PE [13]. Atg8 has been suggested to be required for elongation of
the autophagosomal membrane; in vitro experiments have re-
vealed that Atg8 can mediate the tethering and hemifusion of lip-
osomes containing Atg8–PE [14]. These conjugation pathways are
well conserved in mammalian cells where lipidation of one of
the six mammalian homologues of Atg8, LC3, and in particular
the GFP-tagged version, GFP–LC3, is widely used to monitor
autophagy.
Most of the autophagy machinery is also utilised for the biosyn-
thetic cytoplasm-to-vacuole targeting (Cvt) pathway in yeast
[15,16]. The Cvt pathway involves selective sequestration of the
vacuolar hydrolases a-mannosidase (Ams1) and a precursor form
of aminopeptidase I (prApe1) into double-membrane Cvt vesicles
that exclude bulk cytoplasm following binding to cargo receptor
such as Atg19, a cargo receptor for prApe1 and Ams1 [17]. The
Cvt pathway has not yet been identiﬁed in higher eukaryotes.
Examples of other types of selective autophagy are also known in
both yeast and mammalian cells, such as mitophagy and pexo-
phagy, which involve selective sequestration of mitochondria and
perioxisomes, respectively, and mammalian cells, for instance, pro-
tein aggregates and invading bacteria can be selectively incorpo-rated into autophagosomes and targeted for degradation (for
review see [18]).2. Regulation of yeast Atg9 trafﬁcking
Although work in Saccharomyces cerevisiae is beginning to unra-
vel the molecular mechanisms of autophagy, a number of ques-
tions remain unanswered including the nature of the PAS and the
origin of the autophagosome membrane. The autophagosome
membrane is proposed to originate from either a pre-existing orga-
nelle or be formed de novo by localised lipid synthesis. Various
organelles have been suggested to supply membrane including
the ER and the Golgi complex, although characterisation of the
autophagosome membrane isolated from mammalian cells was
found to lack known protein markers from these suggested ‘donor’
organelle membranes [19]. Atg9 has been the focus of many exper-
iments aimed at answering this question, as it is the only con-
served multi-spanning membrane protein that is essential for
autophagy and therefore the best candidate to mark the source
of the membrane.
Atg9 has six highly conserved transmembrane domains and
cytosolic NH2- and COOH-terminal domains that are divergent in
both length and sequence. It was originally identiﬁed in yeast ge-
netic screens for defects in both the Cvt and autophagic pathways.
Atg9 deﬁcient cells do not mature prApe1, are unable to accumu-
late autophagic vesicles in the vacuole in the presence of the pro-
teinase B inhibitor PMSF and display a reduced survival rate during
nitrogen starvation [20,21]. Using live-cell imaging, ﬂuorescently
tagged Atg9 is observed to localise to the PAS as well as to several
dispersed punctate structures that are scattered throughout the
yeast cytoplasm [20,22]. This is in contrast to most other Atg pro-
teins, which are found to reside only at the PAS, and are otherwise
diffuse in the cytosol [5]. The peripheral pool of Atg9 partially co-
localises with protein markers of mitochondria and it has been
speculated that Atg9 resides either in the mitochondria or within
vesicles in very close apposition to the mitochondria [23]. Atg9
also co-fractionates with protein markers of the Golgi complex
by density gradient analysis suggesting that a population of Atg9
also localises to this compartment [24]. Reggiori et al. [22] have
shown that Atg9 cycles between the PAS and peripheral pool,
which is facilitated by the interaction of Atg9 with multiple bind-
ing partners.
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Under nutrient-rich conditions, the PAS localised population of
Atg9 depends upon interaction with the peripheral membrane pro-
tein Atg11 via its N-terminal domain (Fig. 2A), and this interaction
is facilitated by actin [25]. Perturbation of the actin cytoskeleton
with the drug Latrunculin A disrupts Atg11 localisation to the
PAS and therefore inhibits Atg9 trafﬁcking to this compartment
[26]. Furthermore, Atg9 binds directly to the actin related protein,
Arp2, and is found to be immobile in the periphery of the cell in
arp2-1 mutants [27]. Localisation of Atg9 to the PAS is required
for Cvt vesicle formation; indeed, atg9D cells are unable to process
prApe1 into its mature form. In the absence of the Cvt complex
(Atg19 bound to the cargo proteins prApe1 and Ams1) trafﬁcking
of Atg9 to the PAS is defective, which suggests that trafﬁcking of
Atg9 is initiated by the presence of the cargo complex. Atg9 cycling
was also found to require the peripheral membrane protein Atg23
and the type I membrane protein Atg27. These proteins localise to
the PAS and peripheral pools forming a cycling complex with Atg9
[28]. There are so far no known mammalian homologues of Atg11,
Atg23 or Atg27.
During autophagy, the localisation of Atg9 to the PAS is inde-
pendent of Atg11 and actin and instead depends upon physical
interaction with Atg17 (Fig. 2B). Atg17 acts as a scaffold for PAS
organisation and this process requires the protein kinase Atg1
[29]. Although Atg23 and Atg27 are required for efﬁcient trafﬁck-
ing of Atg9 during autophagy as in the Cvt pathway, they are not
essential as autophagosomes still form in atg23 and atg27 mutants
although the generated autophagosomes are smaller [30,31]. In
contrast in atg9D cells no autophagosomes form resulting in a re-
duced survival rate and total protein turnover during starvation
[20,21].Fig. 2. Atg9 trafﬁcking in yeast. (A) In nutrient-rich conditions Atg9 is present on both th
vesicles closely associated to the mitochondria. Atg9 forms a cycling complex with the typ
is required for Atg9 trafﬁcking to the PAS. Atg11 associates independently with the PA
Retrieval of Atg9 from the PAS to the peripheral pool requires the PI3K complex and Atg1
and Atg2 resulting in the formation of a functional complex enabling Atg9 trafﬁc back
which is facilitated by Atg1. Atg23 and Atg27 are bound to Atg9 forming a cycling comp
occurs as in the Cvt pathway. Abbreviations: Atg 1, 1; Atg2, 2; Atg11, 11; Atg13, 13; AtRecent data suggests that yeast Atg9 is able to self-interact dur-
ing nutrient-rich and starvation conditions to form a multimeric
Atg9-containing complex that is required for trafﬁcking of Atg9
to the PAS in both the Cvt pathway and autophagy [32]. Atg9 is ob-
served to localise to a cup-like structure that is speculated to rep-
resent the growing autophagosome or phagophore, the formation
of which is dependent upon the ability of Atg9 to self interact. A
loss-of-self interaction Atg9 mutant (Atg9D766–770) results in
fragmentation of this structure, apparent loss of membrane at
the PAS and the formation of abnormal autophagosomes. This
has led to speculation that Atg9 trafﬁcking to the PAS may partic-
ipate in supplying membrane, as well as mediating tethering and
fusion of small membranes to the forming autophagosome [32].
4. Retrograde transport of Atg9
Atg9 is not present on autophagic vesicles that accumulate in
the vacuole upon addition of PMSF, and thus it is assumed that
Atg9 is absent from the completed autophagosomes, which fuse
with the vacuole. The retrieval of Atg9 from the PAS and/or the
closed autophagosome to the peripheral pool involves the Atg1–
Atg13 complex, the Atg9 binding partners Atg2 and Atg18, which
form a complex, and the PI3K complex [22]. This retrieval pathway
is required for both the Cvt pathway and autophagy. Indeed, in the
absence of any of these proteins Atg9 accumulates at the PAS and
autophagy is defective.
The proposed model involves the independent association of
Atg9, Atg1 and the PI3K complex with the PAS that leads to the
membrane recruitment of the PI3P-binding protein, Atg18, and
the peripheral membrane protein, Atg2. The interaction and asso-
ciation of these proteins with Atg9 at the PAS results in the forma-
tion of a functional complex that allows Atg9 retrieval to thee PAS and a dispersed peripheral pool that is suggested to be either mitochondria or
e I membrane protein Atg27 and peripheral membrane protein Atg23. This complex
S and is required for recruitment of Atg9 to the PAS, which is facilitated by actin.
which associate separately to the PAS and recruit the Atg9 binding proteins Atg18
to the peripheral pool. (B) During starvation, Atg9 is recruited to the PAS by Atg17
lex, which is required for efﬁcient Atg9 trafﬁc. Retrieval back to the peripheral pool
g18, 18; Atg23, 23 and Atg27, 27.
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the PAS continuously during the formation of an autophagosome
or whether only one cycle of Atg9 transport is carried out. This
question may be important in determining whether Atg9 is re-
quired for the delivery of lipids to the forming autophagosome.
Whereas one cycle of Atg9 could deliver a ﬁxed amount of lipid
to the forming autophagosome, the same number of Atg9 mole-
cules that are continuously cycling would be able to deliver more
lipid. A role for Atg9 in the initiation of autophagosome formation
may require only one cycle of Atg9 trafﬁc to the PAS, whereas the
delivery of lipids and thus expansion or propagation of autophago-
somes is likely to require continuous cycling of Atg9 to the PAS. A
caveat of this model is that Atg9 retrieval from the autophagosome
would require a loss of lipids from the forming and/or completed
autophagosome. The autophagic machinery may be able to com-
pensate for this recruiting more lipids in the case of anterograde
trafﬁc to the PAS and fewer lipids in the retrograde pathway back
to the peripheral pool. This would also explain why different
machinery is required for trafﬁcking of Atg9 to the PAS during
either the Cvt pathway or bulk autophagy, as the Cvt vesicles are
much smaller in size than autophagosomes. Therefore, under-
standing the dynamics of Atg9 trafﬁc may provide further insight
into the role for Atg9 in autophagosome biogenesis.
Overall, the yeast model and data provide a clear picture of the
network of Atg proteins controlling Atg9 localisation. This informa-
tion together with the data regarding the role of actin has provided
a detailed model for trafﬁcking of Atg9 in the Cvt pathway and
autophagy. It is worth noting again, however, that the cytoplasmic
domains of Atg9 are variable in higher eukaryotes, which suggests
that there maybe different mechanisms for the regulation of Atg9
trafﬁcking amongst species.5. Mammalian Atg9
Atg9 homologues exist in all species so far examined, and
although its function is still unknown, it is required for autophagy
in all species studied. Deletion of the C. elegans ORF T22H9.2, the
orthologue of yeast Atg9, is found to shorten the life span of worms
and increases the embryonic lethality of Cup-5 embryos that re-
quire autophagy for survival [33]. Furthermore, siRNA-mediated
knockdown of Drosophila melanogaster Atg9 in S2 cells results in
an increase in vesicular stomatitis virus (VSV) infection due to a
defect in autophagy, which would normally limit VSV replication
[34]. Finally, knockout of Atg9 in plants results in accelerated leaf
senescence again due to a defect in autophagy [35].
In mammalian cells, there are two functional orthologues of
Atg9, namely AtgL1 and Atg9L2. Whereas AtgL1 (mAtg9 hereafter)
is ubiquitously expressed, Atg9L2 is only found expressed in the
placenta and pituitary gland [36]. siRNA-mediated knockdown of
mAtg9 was found to inhibit LC3 lipidation and protein degradation
in HEK293 cells [36,37] suggesting that mAtg9 is required for the
autophagic pathway in mammalian cells as well. Most recently,
mAtg9 knock out mice have been generated, and mAtg9 has been
shown to be required for survival immediately after birth, an iden-
tical phenotype to Atg5 knock out mice [38].
In nutrient-rich conditions, and similar to yeast where Atg9 is
observed to trafﬁc between a single PAS and peripheral structures
[22], mAtg9 has a dual localisation being found in a juxta-nuclear
region as well as in a dispersed peripheral pool [37]. The juxta-nu-
clear pool of mAtg9 has been shown to co-localise with protein
markers of the trans-Golgi network (TGN), while the peripheral
pool partially co-localises with the endosomal protein markers
Rab5, Rab7 and Rab9. The difference between the localisation of
yeast Atg9 and mAtg9 appears so far to be restricted to the identity
of the two compartments or involved in its cycling. During nutrientstarvation, loss of mAtg9 from the juxta-nuclear pool coincides
with an increase in the peripheral pool and co-localisation with
protein markers of autophagosomes including GFP–LC3 [37]. The
localisation of mAtg9 with either GFP–LC3 alone or GFP–LC3 and
Rab7 together suggests that mAtg9 is found on both immature
autophagosomes (GFP–LC3-positive) and degradative autophago-
somes (GFP–LC3 and Rab7 positive). Subcellular fractionation and
isolation of mAtg9 and LC3-positive autophagosomes from rat
hepatocytes supports this observation (A. Young and S.A. Tooze,
unpublished data). This is in contrast to yeast, where mAtg9 is
not found on completed autophagosomes. However, following re-
addition of nutrients and in the presence of cyclohexamide, a pro-
tein synthesis inhibitor, mAtg9 can cycle back from the peripheral
pool to the juxta-nuclear pool suggesting that a retrieval pathway
from forming autophagosomes exists. Further work is required to
determine if mAtg9 is found on autolysosomes, and if a small
amount of mAtg9 is degraded during autophagy.
Starvation dependent trafﬁcking of mAtg9 requires the Atg1
orthologue, Unc-51 like kinase (ULK1), and mammalian Atg13
[37,39]. As in yeast, ULK1 and mAtg13 are in a complex with the
functional orthologue of Atg17, FIP200 (reviewed by Ref. [40]).
However, the requirement for FIP200 in mAtg9 trafﬁcking remains
to be tested. Inhibitors of the PI3K complex were also found to in-
hibit dispersal of mAtg9 during starvation suggesting that trafﬁck-
ing of mAtg9 is also dependent upon this regulatory complex [37].
Although mammalian homologues of Atg18 and Atg2 exist, they
are yet to be characterised in terms of mAtg9 trafﬁcking.
Analysis of mAtg9 on isolated autophagosomes by electron
microscopy conﬁrmed the presence of mAtg9 on the membranes
of autophagosomes, as well as on internal sequestered membranes
(A. Young and S.A. Tooze, unpublished data). Recent data using iso-
lated membrane fractions from HEK293 cells show that GFP-
mAtg9 has an asymmetric distribution on these membranes in
contrast to GFP-tagged LC3, Atg16 and Atg5 that appear to have
a more uniform distribution [41]. It cannot be excluded that, due
to the hydrophobic nature of mAtg9, these structures are gener-
ated by the isolation procedure. However, while the function of
the mAtg9 in these concentrated regions on the autophagosome
membrane is not known, it has been speculated that mAtg at these
regions may represent docking sites for fusion of incoming vesicles
with forming autophagosomes. Furthermore, preliminary experi-
ments using exogenous proteins suggested a co-localisation of
mAtg9 and Bif-1 [42], a member of the endophilin family, which
can bind to membranes and induce curvature via a BAR domain,
has led to speculation that these two proteins may interact. Fusion
of Bif-1 positive vesicles with mAtg9 positive compartments leads
to the formation of a cup-like structure that is similar to that ob-
served in yeast [42], possibly supporting the idea that mAtg9
may deliver small vesicles to forming autophagosomes and recruit
machinery to remodel the membrane.
The picture emerging from these data suggests the dynamic
localisation of mAtg9 is important for the formation of autophago-
somes, and as such may be subject to regulatory controls. While
from the yeast data we understand some of the Atg molecules in-
volved in the control of its cycling, in mammalian cells with the
exception of Bif-1 there have been no other reports of proteins
which interact with mAtg9. Recently, using the C-terminal cyto-
plasmic domain of mAtg9 we have found that p38IP (p38 interact-
ing protein) binds to mAtg9 and is required for its trafﬁcking
during starvation [43] (Fig. 3).6. Regulation of mAtg9 trafﬁcking by p38IP
p38IP, which is also known as family with sequence similarity
48 (FAM48), contains a nuclear localisation sequence, a PEST
Fig. 3. mAtg9 trafﬁcking. (A) In full growth conditions Atg9 localises to the TGN and a dispersed endosomal pool. Atg9 binds to p38IP in the periphery of the cell. The
interaction between mAtg9 and p38IP is negatively regulated by the MAPK p38a, which is basally phosphorylated in nutrient-rich conditions. (B) During starvation the pool
of phosphorylated p38a is depleted resulting in an increase in dispersal of mAtg9 that is facilitated by p38IP. Dispersal of mAtg9 to the peripheral pool also requires ULK1 (1),
mAtg13 (13) and the PI3K complex.
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ises both to the nucleus and a cytoplasmic pool that partially co-
localises with mAtg9. This is in agreement with the ﬁnding that
endogenous p38IP localises to the nucleus and can be seen in a
cytoplasmic pool in HeLa cells [45]. Starvation-dependent mAtg9
trafﬁcking was found to require p38IP as siRNA-mediated deple-
tion of p38IP resulted in the loss of mAtg9 dispersal that is nor-
mally observed following starvation and a retention of mAtg9 at
the juxta-nuclear pool [43]. The small population of p38IP and
mAtg9 that co-localise, in both nutrient-rich and starvation condi-
tions, suggests the interaction of mAtg9 with p38IP may be dy-
namic and may be better visualised by live-cell imaging. p38IP
was identiﬁed in a screen for neural tube closure and gastrulation
defects. Importantly, p38IP was found to bind to p38aMAPK and is
required for its activation during mouse development [44]. Expres-
sion of mutant p38IP, which contains a premature stop codon
resulting in a truncated protein at 317 amino acids, in the mouse
eye results in a reduction in the levels of phosphorylated p38a
and its downstream substrates CREB and ATF2. This p38IP mutant
was found to have an increased incidence of spina biﬁda and exen-
cephaly, whereas a splicing mutant that results in truncation at
133 amino acids had severe gastrulation defects. It is not known
if these phenotypes are due to defects in the activation of p38a
and the proposed downregulation of E-cadherin. However, inhibi-
tion of p38 activity by SB 203580 compound, an inhibitor of MAP-
Kinases did not signiﬁcantly alter the incidence of spina biﬁda or
gastrulation observed [46], which suggests that these defects
may be due to another function of p38IP that is independent of
the activity of p38 MAPK. Similar neural tube closure defects are
observed upon functional deﬁciency of Ambra1, a Beclin1 binding
partner that is involved in autophagy and neuronal development
[47]. These common phenotypes suggest a role for autophagy in
the p38IP mouse mutant phenotype.
As p38IP was identiﬁed as a p38 MAPK interacting partner we
decided to investigate the role of p38 in autophagy and regulation
of mAtg9 trafﬁcking. Depletion of p38 MAPK results in dispersal of
mAtg9 in full medium and leads to an upregulation in LC3 lipida-
tion suggesting that p38 is a negative regulator of autophagy. Fur-
thermore, the function of p38 in autophagy was found to be
dependent upon p38IP, and this data supports the hypothesis that
p38 regulates the interaction between Atg9 and p38IP [43]. p38has previously been implicated in autophagy regulation, although
the ability of p38 to negatively or positively regulate autophagy
appears to be dependent upon the cell type and stimulus used.
For example, whereas we have shown that activation of p38 with
either anisomycin or UV irradiation leads to an inhibition in the
autophagic pathway [43], accumulation of mutant glial ﬁbrillary
acidic protein (GFAP) in astrocytes is found to induce autophagy
via activation of p38 and inhibition of the TOR pathway [48]. It
would be interesting to determine the relationship between Atg9
trafﬁcking and p38 in these conditions.
Interestingly, new data on the regulation of the TOR pathway by
p38 MAPK supports our hypothesis concerning p38 regulation of
autophagy. In A549 cells, p38 activation by anisomycin has been
shown to activate mTOR and S6K [49]. It was under these condi-
tions that we observed an inhibition of Atg9 trafﬁcking and
autophagy. Although we did not analyse TOR phosphorylation di-
rectly we were also able to detect an increase in S6K phosphoryla-
tion, detected by immunoblotting with phospho-speciﬁc S6K
antibodies, following activation of p38 with anisomycin (J. Webber,
S.A. Tooze, unpublished results). p38a-dependent activation of
TORC1 is blocked following siRNA knockdown of the upstream
p38 kinases MKK3 and MKK6 [49]. Interestingly, in contrast, we
ﬁnd that whereas p38a depletion increases GFP-LC3 and LC3 lipi-
dation [43], siRNA-mediated knockdown of MKK6 inhibits GFP-
LC3 lipidation (Ref. [50] and J. Webber, S.A. Tooze, unpublished re-
sults). This suggests that in our cell model, either MKK3 can over-
compensate for loss of MKK6, or alternatively there are potentially
two separate mechanisms for regulation of autophagy by p38, one
via TOR, and the second by inhibition of mAtg9 trafﬁcking and LC3
lipidation.
However, as mentioned above, in certain circumstances p38a
can positively regulate autophagy in an mTOR-dependent manner.
Upon accumulation of mutant glial ﬁbrillary acidic protein (GFAP)
aggregates in Alexander disease, a genetic disorder affecting the
central nervous system caused by mutations in GFAP, p38 MAPK
is activated, and mTOR is inhibited [48]. In these conditions
autophagy is upregulated in order to reduce GFAP levels. This is
opposite to that observed following activation of p38 with aniso-
mycin or UV irradiation, which may suggest that the role of p38
in autophagy is subject to cell type and stimuli speciﬁcity. It would
be important in this instance to examine the role of p38 in other
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Recently p38IP was identiﬁed as a component of the human
SAGA (Spt-Ada-Gcn5-Acetylase) complex, which together with
RNA polymerase II is required for transcriptional regulation of
stress-responsive genes [45,51]. The SAGA complex is found in
yeast, and is comprised of multiple subunits including Spt20.
p38IP is suggested to be a homologue of yeast Spt20, sharing ﬁve
conserved regions within the N-terminal domain. Conservation is
also observed in these regions with putative Spt20 homologues
across species including Drosophila and mice. Yeast Spt20 interacts
with the yeast p38 homologue Hog1, a protein required for osmotic
stress in yeast, although it is not knownwhich region of the protein
is required for this interaction [52]. It is not known whether yeast
Spt20 is also involved in autophagy, however, Hog1 has been
shown to regulate autophagy during high osmolarity in S. cerevisi-
ae: loss of Hog1 results in an inhibition of autophagy during incu-
bation in hypo- or hyper-osmotic conditions [53].
In contrast, binding of p38IP to p38 MAPK has been mapped to
the C-terminal domain of p38IP [44], which is not conserved in
Spt20. Spt20 is also found to have a role in osmotic stress, indeed
during conditions of high osmolarity, deletion of Spt20 resulted
in a strong inhibition in cell growth and a reduction in gene expres-
sion of osmotic stress-responsive genes to a similar extent to that
observed upon deletion of the MAPK kinase PBS2, the mammalian
homologue of which is MKK4 [52]. This is in contrast to the ﬁnding
that p38IP is not recruited to the promoter for stress-induced
genes that are associated with activation of the p38 MAPK pathway
following stimulation with Na-arsenite suggesting that the
involvement of p38IP in the MAPK pathway may be speciﬁc to
the stimulus used to activate p38 [45].7. Function of mammalian Atg9
Although a number of Atg9 binding partners have been identi-
ﬁed for yeast Atg9, and more recently we have shown that mAtg9
can interact with p38IP, we still do not know the function of Atg9
in autophagy. An important study in which quantitative ﬂuores-
cence microscopy was used to follow the kinetics of Atg protein
recruitment to the PAS in yeast [54] has led to the suggestion that
Atg9 may be involved in the regulation of autophagosome size. The
intensity of Atg9 increases at the PAS where it acts in the initial
recruitment of other Atg proteins. It then appears to remain at rel-
atively constant levels during starvation-induced autophagy. As
stated above, Atg9 has also been speculated to be a carrier of lipids
to forming autophagosomes. In atg27D cells (Atg27 is required for
correct Atg9 trafﬁcking), Atg9 trafﬁcking is inhibited upon starva-
tion and fewer autophagosomes of normal size are formed [54].
The atg27 phenotype may therefore be due to the loss of delivery
of Atg9 and its associated lipids to forming autophagosomes
[28,55]. Likewise in rat primary hepatocytes depleted of mAtg9 un-
der conditions where there was no detectable LC3-II, using electron
microscopy smaller autophagosomes were found compared to con-
trol siRNA treated cells (A. Young, S.A. Tooze, unpublished results).
The difference between this result and the ﬁndings in yeast that no
autophagosomes form in atg9D cells may be due to the efﬁciency of
siRNA-mediated knockdown of mAtg9. However, it is possible that
the autophagosomes found in the Atg9 depleted hepatocytes by
electron microscopy are formed using the alternative macroauto-
phagy pathway (see below).
Alternatively the relationship between Atg8 and Atg9 may be
important for regulation of autophagosome size. Deletion of Atg8
results in smaller autophagosomes than those seen in wild-type
cells [56]. As Atg9 has been shown to act upstream of Atg8 lipida-
tion in yeast, loss of Atg9 may lead to a reduction in autophago-some size due to a loss of Atg8 recruitment to the PAS. As Atg8
can facilitate homotypic fusion in vitro, the amount of lipidated
Atg8 may therefore regulate the expansion of the autophagosomal
membrane. In rat hepatocytes, as mentioned above, depletion of
mAtg9 is also associated with an inhibition in LC3 lipidation [37]
which may account for the smaller autophagosomes observed. In
cells depleted of p38IP, mAtg9 remains at the trans-Golgi network
after nutrient starvation and LC3 lipidation and p62 degradation
are inhibited [43] suggesting that p38IP is required for efﬁcient
autophagy in mammalian cells. It is possible that regulation of size
of the autophagosome via interaction of mAtg9 with p38IP would
enable control of the ﬂux through the autophagic pathway and a
ﬁne tuning of autophagy.
Our recent data demonstrates that activation of p38 MAPK can
inhibit mAtg9 trafﬁcking during starvation resulting in a block in
the autophagic pathway [43] supporting our hypothesis that
Atg9 may also act as a control point that can be targeted by up-
stream signaling events. Furthermore, we ﬁnd that p38a can neg-
atively regulate the interaction between mAtg9 and p38IP and thus
we speculate that it is the disruption of mAtg9 trafﬁcking that re-
sults in the inhibition of autophagy. This is the ﬁrst evidence that
suggests mAtg9 may have a role in regulation of autophagy. As
autophagic activity decreases during prolonged starvation [57]
control of degradation would prevent cells from undergoing cell
death. The magnitude of the autophagic response must therefore
be subject to regulation, which we propose could be through
mAtg9 and controlled by p38a.
We have shown that knockdown of p38a in HEK293 cells leads
to an upregulation in LC3 lipidation and Atg9 trafﬁcking in fullmed-
ium suggesting that p38 is a negative regulator of basal autophagy.
To function as a negative regulator p38 should sense the nutrient
status of the cell. Casas-Terradellas et al. [58] have shown that
p38 is activated by amino acids, and this may provide a mechanism
bywhich the phosphorylation status of p38 can be controlled by the
availability of nutrients. Following phosphorylation of p38 with
anisomycin, a loss of the membrane-associated pool of p38IP was
observed alongwith a corresponding decrease in the interaction be-
tween mAtg9 and p38IP. Replenishment of the intracellular amino
acids pool upon autophagic degradation of cellular components
may feedback to inhibit Atg9 trafﬁcking by favouring the p38a–
p38IP interaction and disrupting the Atg9–p38IP interaction and
thereby inhibiting autophagy. Thus re-activation of p38amay pro-
vide an ideal feedbackmechanism to prevent autophagic cell death.
Indeed, inhibition of p38 by SB compound in colorectal cancer cells
leads to an upregulation in the LC3 homologue, GABARAP, and
eventual autophagic cell death [59].
Although Atg9 is an essential protein for starvation-induced
autophagy in yeast and mammalian cells, an alternative form of
autophagy has been recently proposed in mammalian cells that
is independent of Atg5, Atg7 and mAtg9. This alternative non-
canonical autophagy is induced in Atg5/ and Atg7/ MEFs
(mouse embryonic ﬁbroblasts) following treatment with etopo-
side, which induces cell stress via inhibition of topoisomerase II
[60]. In Atg5/ and Atg7/ MEFs autophagosomes were ob-
served by electron microscopy to form following etoposide treat-
ment. The generation of these autophagosomes requires Rab9
and it is speculated that they form following fusion of phagophores
with vesicles derived from the TGN and late endosomes. This alter-
native autophagy was shown to be independent of mAtg9 which is
puzzling as mAtg9 is the only autophagy related protein so far
identiﬁed to reside at both the TGN and late endosomes, and it
co-localises with Rab9 [37]. Furthermore, mAtg9 trafﬁcking is
dependent upon ULK1, which is also required for etoposide-in-
duced autophagy. It is therefore a conundrum that this process
does not require mAtg9 and it remains to be explained how and
where the autophagosomes originate. It will be interesting to
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ulate that its mechanism of action is via regulation of mAtg9 traf-
ﬁcking we would predict that this mAtg9-independent autophagy
would also be independent of p38a.
Most recently, a novel function for mAtg9 has been described in
the regulation of innate immunity following double-stranded DNA
(dsDNA) stimulation [38]. A multi-spanning membrane protein,
stimulator of IFN genes (STING), is a regulator of IFN production
assembling into a complex with TANK-binding kinase 1 (TBK1) in
the cytoplasm following dsDNA stimulation. The formation of
STING-TBK1 structures is negatively regulated by mAtg9, as shown
by an enhanced co-localisation of STING and TBK1 in mAtg9-
knockout MEFS. It will be interesting to test if this function is
dependent upon p38IP and p38 MAPK. p38 MAPK has previously
been shown to be involved in IFN production although to the best
of our knowledge there is no evidence for regulation of p38 MAPK
by dsDNA [61]. This is the ﬁrst report that mAtg9 has a function
other than in autophagy. It is not known if this process is related
to autophagy although other Atg proteins do not regulate STING
localisation. Furthermore, Atg7 and Atg16 are not required for
IFN production stimulated by dsDNA suggesting that this response
is independent of autophagy. Interestingly, the Atg12–Atg5 conju-
gate acts as a suppressor of innate immune responses and can
associate with RIG-1 and IPS-1 which are required for recognition
of RNA virus infection and function upstream of TBK1 and enables
upregulation of IFN. RIG-1 is also required for dsDNA recognition
leading to TBK dependent IFN production [62]. Although the
Atg12–Atg5 conjugate have not been shown to suppress the im-
mune response following dsDNA stimulation it is tempting to spec-
ulate that this may also be regulated by the Atg12–Atg5 conjugate.
8. Concluding remarks
Atg9 trafﬁcking has been well characterised in yeast and
although no direct evidence for a role of Atg9 trafﬁcking in regula-
tion of autophagosome size exists a model is emerging. Whether
this function is direct or via an interaction with Atg8 lipidation re-
mains to be explored. It would be interesting to determine the size
of autophagosomes that are observed to form independently of
Atg7, Atg5 and Atg9 in the same system. In contrast, mAtg9 has
not been extensively studied although our recent data implicates
it as an important protein for regulation of autophagy through ac-
tion of the p38 MAPK. It remains to be seen whether this is true in
all cases of autophagy or if it is speciﬁc to starvation-induced
autophagy. Furthermore, p38 MAPK appears to be able to regulate
the TOR pathway and may be able to provide a negative feedback
mechanism to limit the extent of autophagy that occurs. As p38 is
also known to be an important protein in the control of apoptosis
(reviewed by Ref. [63]), this may provide the link between the two
cell death pathways. Understanding further novel interacting part-
ners of mAtg9 will enable us to gain insight into the function of
mAtg9 in autophagy and in other pathways.
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